chadox1 rvf
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2020 (NCT04672824)
Timeline
Indications
Mechanism of action
- Rift Valley fever virusImmunity, active
Rift Valley fever virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06799234 | Phase 2 | Feb 28, 2025 | University of Oxford |
| NCT04754776 | Early Phase 1 (Phase 1) | Jun 11, 2021 | University of Oxford |
| NCT04672824 | Phase 1 | Dec 31, 2020 | Medical Research Council-UVRI Uganda Research Unit on AIDS, University of Oxford |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 3 | 3 | 2 | 2020 |
| Medical Research Council-UVRI Uganda Research Unit on AIDS | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1